ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,322.94
-0.19%
Brent Oil
80.835
0.04%
Bitcoin
68,643.40
1.32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Forma Therapeutics Holdings Inc (FMTX)

  7. Forma Therapeutics Holdings Inc (FMTX) News

Forma Therapeutics (FMTX)

Forma Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FMTX
DateTimeSourceHeadlineSymbolCompany
14/02/202313:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
24/10/202216:23Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202221:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202214:25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202214:24Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202214:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202214:00Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202213:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FMTXForma Therapeutics Holdings Inc
07/10/202213:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
07/10/202213:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
30/09/202214:00Business WireSickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the DiseaseNASDAQ:FMTXForma Therapeutics Holdings Inc
28/09/202214:37Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
28/09/202213:34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
15/09/202222:26Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:FMTXForma Therapeutics Holdings Inc
15/09/202222:22Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FMTXForma Therapeutics Holdings Inc
02/09/202221:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202222:23Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202215:19Dow Jones NewsForma Therapeutics Shares Surge on Takeover by Novo NordiskNASDAQ:FMTXForma Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:FMTX

Your Recent History

TSXV
PGY
BIT
S29094
Societe Generale Effekten
BIT
I06001
Banca Imi
BIT
I07185
INTESA SANPAOLO
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved